654 related articles for article (PubMed ID: 32321469)
1. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
4. The Association of Long Non-Coding RNA SNHG6 Expression with Clinicopathological Features and Prognosis in Cancer.
Wu Y; Zhang Y; Zhu X; Liu H
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710436
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic value of LINC01296 in cancers: a meta-analysis.
Feng W; Zhai C; Shi W; Zhang Q; Yan X; Wang J; Wang Q; Li M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3315-3321. PubMed ID: 31385542
[No Abstract] [Full Text] [Related]
7. Prognostic significance of lncRNA DANCR expression in human cancers: a systematic review and meta-analysis.
Liu W; Wang QP; Guo J
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 30910838
[TBL] [Abstract][Full Text] [Related]
8. LncRNA AWPPH as a prognostic predictor in human cancers in Chinese population: evidence from meta-analysis.
Li Y; Rui X; Chen D; Xuan H; Yang H; Meng X
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34042153
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
10. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
Zhang C; Ren X; Liu Z; Tu C
BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysis.
Cheng XB; Fu B; Li XZ; Jiang Y
Pathol Res Pract; 2020 Jun; 216(6):152949. PubMed ID: 32307201
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis.
Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A
Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
[No Abstract] [Full Text] [Related]
16. Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis.
Shi D; Wu F; Gao F; Qing X; Shao Z
PLoS One; 2017; 12(6):e0179346. PubMed ID: 28594897
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.
Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y
J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NORAD as a Novel Predictor of Lymph Node Metastasis and Prognosis in Solid Tumors: A Systematic Review and Meta-Analysis.
Ye T; Ye Z
Technol Cancer Res Treat; 2020; 19():1533033820963586. PubMed ID: 33016254
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis.
Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
